Patent · US Active

Method for evaluating risk in multiple sclerosis

US8048639B2 · kind B2 · utility

0Cited by
5References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 11, 2010
Grant dateNov 1, 2011
Priority date—
Expiry dateApr 25, 2030

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/56
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The invention relates to methods and reagents for diagnosing and assessing the prognosis of multiple sclerosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.